Indication
NY-ESO-1 Expressing Solid Tumors
1 clinical trial
2 products
1 drug
Clinical trial
Phase Ib Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2024-09-01
Drug
cyclophosphamideProduct
TBI-1301Product
Fludarabine